Abstract:Abstract Background Lung cancer in very young adults in China aged <30 is on the rise and the clinicopathological characteristics of this unique population are incomplete and are yet to be elucidated. Our study aims to explore the characteristics, trends and distinctive features of lung cancer this age group to provide more information that can aid in developing optimal treatment regimens and improve prognosis for this exclusive age group. Method A retrospective review of 141 lung cancer patients admitted at our hospital from August 2011 to October 2021 was performed. The focused age group in our study was 18-30 years old. The data collected included demographics, tumor pathology, gene mutations, and treatment. Overall survival and prognosis were systematically analyzed. Results From a total of 141 of young lung cancer patients, 139 were included in final analysis. The gender distribution in our series favored female(65.5%), and only 7.2% of the study cohort had a history of smoking. Adenocarcinoma was the most common histological type in our study, presenting 93.5% of all patients. The most common stages at diagnosis was stage I(61.2%) and stage IV(30.2%). Genetic testing was performed in only 24.5% (34/139) of the patients. From the 23/34 patients in our study who tested positive for a genetic mutation, 19 (82.3%) were stage IV. The most common gene mutation was Anaplastic Lymphoma kinase(ALK) rearrangement observed in 13/23 (56.5%) gene mutation positive patients. Among stage IV NSCLC, OS was longer in patients who received targeted therapy, compared to the patients not receiving target therapy: 88 months vs 24 months (95% CI: 0.15-1.0, p=0.0282). Conclusion Lung cancer in the young adult population has particular characteristics (Common in female, non-smoker and adenocarcinoma patients). Higher stages of disease were observed in those with a gene mutation (notably ALK rearrangement). Although the sample size was small, the current data suggests a higher mutation rate in the younger population. These findings have fundamental implications for practice and we propose that all patients under 30 diagnosed with lung cancer should undergo genetic testing so they can receive personalized treatment and therefore achieve better outcomes.

Analysis of Survival Data in Patients with Advanced Non-Small-Cell Lung Cancer Aged 60 Years and Over

Comparison between young and old patients with lung cancer

Analysis of the Characteristics and Prognosis of Advanced Non-Small-Cell Lung Cancer in Older Patients

Prognostic Factors in Older Patients with Advanced Non-Small Cell Lung Cancer in China.

[A Retrospective Analysis: Comparison of the Clinical Characteristics and Prognosis in Elderly and Young Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer.].

[Multivariate Analysis of Prognostic Factors in the Eldly Patients with Small Cell Lung Cancer: a Study of 160 Patients].

[Analysis of Prognostic Factors in 541 Female Patients with Advanced Non-Small Cell Lung Cancer].

Correlation Study Between Advanced Age and Inferior Prognosis in Stage Ⅱ Colorectal Cancer Patients

Clinical analysis of 141 cases of elderly patients with lung cancer

A Clinical Analysis of Lung Cancer in Elderly Patients

Analysis on Prognostic Factors of Long-term Outcomes in Elderly Patients with Early-stage NSCLC Treated by Video-assisted Thoracoscopic Surgery

Clinicopathological features and prognosis of young patients with non-small cell lung cancer

Demographics, Risk Factors and Survival Analysis of Lung Cancer in Young Adults (&lt;30 Years) in China-A Retrospective Cohort Study

Impact of age on adjuvant chemotherapy after radical resection in patients with non-small cell lung cancer

Survival and Outcomes of Surgical Treatment of the Elderly NSCLC in China: a Retrospective Matched Cohort Study.

The evaluations of different age advanced non-small-cell lung cancer patients treated with docetaxel plus platinum combination chemotherapy

Clinical retrospective observation of lung cancer between young and elderly patients

Efficacy of Platinum Drugs in the Treatment of Elderly Patients with Advanced Non-Small Cell Lung Cancer and Their Effects on Prognosis and Survival.

Compared survival analysis between elder and younger patients with late stage of non-small cell lung cancer on chemotherapy

Analysis of Prognostic Factors of Sequential Treatment in 355 Patients with Advanced Non-Small Cell Lung Cancer

The impact of age on the survival outcomes and risk of radiation pneumonitis in patients with unresectable locally advanced non -small cell lung cancer receiving chemoradiotherapy